Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof

a technology of hepatitis a virus and nucleotide sequences, applied in the field of viral diagnostics, can solve the problems of low yield of virus, difficult direct manipulation of viral genome, and poor growth of virus in cell cultur

Inactive Publication Date: 2005-06-16
CHIRON CORP
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

HAV grows poorly in cell culture, is not cytopathic, and produces low yields of virus.
Although HAV RNA extracted from virions is infectious in cell culture (Locarnini et al., J. Virol. 37:216-225, 1981 and Siegl et al., J. Gen. Virol. 57:331-341, 1981), direct manipulation of the viral genome becomes difficult because of its RNA composition.
The development of sensitive and specific diagnostic assays to identify HAV antigens and / or antibodies in infected individuals as well as nucleic acid-based tests to detect viremic samples to exclude them from transfusion represents an important public health challenge.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
  • Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
  • Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Hepatitis A Nucleic Acid Extraction for RT-PCR

[0147] Human serum samples that had previously tested positive for HAV by IgM anti-HAV ELISA [ETI-HA-IgMK PLUS; DiaSorin, Inc; Saluggia (VC), Italy] were used to isolate RNA for subsequent experiments. Samples were stored at −80° C. until used. RNA was extracted from 0.14 mL of serum using the QIAamp Viral Mini Spin Kit (QIAGEN, Valencia, Calif.) following the manufacturer's specifications.

example 2

Detection of Hepatitis A Nucleic Acid-Positive Samples by RT-PCR

[0148] The RT-PCR was performed using the Titan One Tube RT-PCR Kit (Roche, Mannheim, Germany) to amplify a 243 bp fragment in the VP3 / VP1 region. The 243 bp fragment corresponds to nucleotide positions 2172-2415 of the HAV genome as reported by Cohen et al. (1987) J. Virol. 61: 50-59.

[0149] Experiments were performed using the primers shown in Table 1 and the procedures described below.

TABLE 1Primers used in the “RT-PCR” ExperimentsSEQPCRGenomicIDPrimerSequenceproductregionNO:SN2172GCTCCTCTTTATCATGCTATGGAT243 bpVP3 / VP149SN2415GAGGAAATGTCTCAGGTACTITGT243 bpVP3 / VP150

For this experiment, the “RT-PCR” was performed in a final volume of 50 μL using 10 μL of extracted HAV RNA following the manufacturer's specifications. The amplification profile involved reverse transcription at 50° C. for 30 min., template denaturation at 94° C. for 2 min., denaturation at 94° C. for 30 sec., primer annealing at 55 ° C. for 30 sec. and...

example 3

Cloning of Hepatitis A Fragments

[0151] The PCR fragments were cloned into TOPO-TA vectors (Invitrogen, Carlsbad, Calif.). Cloning into these vectors is highly facilitated when the amplified DNA contains a single deoxyadenosine (A) at its 3′ end. Accordingly, a catalytic reaction to add the 3′ (A) overhead was used. The reaction mix contained 1.25 mM of dATP, 0.5 units of Taq polymerase (Perkin Elmer, Boston, Mass.) and proceeded at 72 C for 15 min.

[0152] PCR fragments were cloned into the pCR2.1-TOPO vector using the Invitrogen's TA cloning kit (TOPOTM TA CloningR Kit with One Shot TOP10 Electrocompetent Cells) following the manufacturer's specifications. Bacterial cells were incubated at 37° C. on Luria Broth plates containing ampicillin at 100 μg / mL, 0.66 mM IPTG and 0.033% X-Gal. A number of white colonies were inoculated in 4 mL of Luria-Broth ampicillin (100 μg / ml) and incubated overnight at 37° C. with shaking. Three mL of the overnight cultures were used to prepare plasmid ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
temperaturesaaaaaaaaaa
temperaturesaaaaaaaaaa
temperaturesaaaaaaaaaa
Login to view more

Abstract

Hepatitis A virus primers and probes derived from the capsid proteins and junction between the capsid precursor P1 and 2A of the HAV genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes, antigen detection of HAV, and immunoassay for detecting the antibodies that bind to HAV.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application is related to provisional patent applications Ser. No. 60 / 328,933 filed Oct. 12, 2001, from which priority is claimed under 35 USC §119(e)(1) and which application is incorporated herein by reference in its entireties.TECHNICAL FIELD [0002] The present invention pertains generally to viral diagnostics. In particular, the invention relates to nucleic acid and antibody-based assays for accurately diagnosing hepatitis A virus infection. BACKGROUND OF THE INVENTION [0003] Hepatitis A is an enterically transmitted disease that causes fever, malaise, anorexia, nausea, abdominal discomfort and jaundice. The etiologic agent of hepatitis A, the hepatitis A virus, is a small, nonenveloped, spherical virus classified in the genus Hepatovirus of the Picornaviridae family. The HAV genome consists of a single-strand, linear, 7.5 kb RNA molecule encoding a polyprotein precursor that is processed to yield the structural proteins and en...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/00G01N33/576A61K39/29A61P31/14C07H21/04C07K14/02C07K14/10C12N5/06C12N7/00C12N15/09C12N15/51C12P21/02C12Q1/68C12Q1/70C12R1/93G01N21/78
CPCA61K39/00C12Q1/706C12N2770/32422C07K14/005A61P31/14Y02A50/30
Inventor PICHUANTES, SERGIO
Owner CHIRON CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products